21 CFR 862.1470
§ 862.1470 Lipid (total) test system.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 862.1470, § 862.1470 Lipid (total) test system, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/89137
- Permanent ID
ys:prov:89137@1- SHA-256
bc403511a9e3173b4dd9b1f0868657f8d46f28906e1e08711243829dcad43b3e
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Identification. A lipid (total) test system is a device intended to measure total lipids (fats or fat-like substances) in serum and plasma. Lipid (total) measurements are used in the diagnosis and treatment of various diseases involving lipid metabolism and atherosclerosis.
(b) Classification. Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.